IBS vs IBD — What's the Difference?

IBS (Irritable Bowel Syndrome) and IBD (Inflammatory Bowel Disease) are among the most commonly confused conditions in gastroenterology. The abbreviations are similar, some symptoms overlap, and both affect the digestive system. But they are fundamentally different in their nature, their investigation, their treatment and their long-term implications — and understanding the distinction is clinically important.

The Core Difference

The most important distinction is this: IBS is a functional disorder; IBD is an autoimmune disease.

IBS involves no immune response. The gut looks entirely normal on investigation — there is no inflammation, no ulceration, no damage to the intestinal lining. Symptoms arise from changes in how the gut functions: altered motility, visceral hypersensitivity and disrupted gut-brain communication. The immune system is not attacking the gut. A colonoscopy in a person with IBS appears normal, and blood markers of inflammation are not elevated.

IBD is driven by an abnormal immune response. In Crohn's disease and ulcerative colitis, the immune system mistakenly identifies the lining of the gastrointestinal tract as a threat and mounts an attack against it. This produces chronic, sustained inflammation that causes real structural damage — visible ulceration, bleeding, thickening of the bowel wall, and over time, scarring and narrowing of the intestine. It is this misdirected immune response, not a functional communication problem, that defines IBD and separates it categorically from IBS.

This immune-versus-functional distinction explains why the two conditions require completely different management. IBS responds to dietary modification, gut-brain therapies and lifestyle change — interventions that address functional and neurological dysregulation. IBD requires medications that directly suppress or modulate the immune response: aminosalicylates, corticosteroids, immunosuppressants and biologics. Treating IBD with a Low-FODMAP diet alone would be as inappropriate as treating IBS with immunosuppressants.

What is IBD?

Inflammatory Bowel Disease is an umbrella term for two distinct conditions: Crohn's disease and ulcerative colitis. Both involve chronic, relapsing inflammation of the gastrointestinal tract — but they differ in location and pattern.

Crohn's disease can affect any part of the GI tract from mouth to anus, and inflammation occurs in patches that extend through all layers of the bowel wall. Ulcerative colitis is confined to the colon and rectum, and inflammation is continuous and limited to the innermost lining (mucosa). Both conditions involve periods of active disease (flares) and remission.

IBD is an immune-mediated condition — the immune system abnormally attacks the gut, producing the characteristic inflammation. The exact cause is not fully understood but involves a combination of genetic predisposition, gut microbiome alterations, environmental triggers and immune dysregulation.

Symptom Comparison

A key clinical flag: IBS does not typically cause rectal bleeding, unintentional weight loss, nocturnal symptoms that wake you from sleep, or fever. If you have a diagnosis of IBS and are experiencing any of these, see your GP — they are alarm features that warrant further investigation regardless of a prior IBS diagnosis.

Diagnosis and Investigation Comparison

Faecal calprotectin is the most useful first-line test for distinguishing IBS from IBD in primary care. It is a stool test that measures a protein released by white blood cells in an inflamed gut. A normal result makes IBD very unlikely and supports an IBS diagnosis; an elevated result prompts referral for colonoscopy. Your GP can request this test.

Treatment Comparison

Can You Have Both IBS and IBD?

Yes — it is possible to have both conditions simultaneously. People with IBD in remission sometimes continue to experience IBS-type symptoms (bloating, altered bowel habit, abdominal pain) even when objective markers of inflammation are normal. Research suggests this occurs in a significant minority of IBD patients and may reflect lasting changes to gut motility or visceral sensitivity caused by prior inflammation.

Managing this overlap requires careful coordination: treating underlying IBD inflammation takes priority, but IBS-directed approaches (dietary modification, psychological therapies) may be helpful for residual functional symptoms once IBD is in remission. This should always be guided by a gastroenterologist.

When to See Your GP

If you have not yet been assessed by a GP for your bowel symptoms, do so. Do not attempt to self-diagnose IBS or assume your symptoms are not IBD without clinical assessment. The following features in particular require prompt GP review:

• Rectal bleeding or blood in the stool
• Unintentional weight loss
• Symptoms that wake you at night
• Persistent fever alongside bowel symptoms
• A first presentation of bowel symptoms after the age of 50
• A family history of IBD or colorectal cancer

These features do not necessarily indicate IBD or anything serious — but they need investigation to rule it out. IBS is a diagnosis of exclusion, reached after other conditions have been appropriately considered.

Related Articles

26 May 2025Understanding IBS

What is IBS? Symptoms, Types and Diagnosis

Read Article →

9 June 2025IBS in Ireland

IBS in Ireland — HSE Resources and Finding a Specialist

Read Article →